Drug Information

Drug General Information
Drug ID
D0Q3QS
Former ID
DIB013800
Drug Name
4-aminosalicylate sodium (oral controlled release, ulcerative colitis), AGI Therapeutics
Synonyms
AGI-022; Salicylate prodrug (oralcontrolled release, ulcerative colitis), AGI Therapeutics; 4-ASA-Na; 4-ASA-Na (oral, controlled release), AGI Therapeutics
Indication Inflammatory bowel disease [ICD9: 555, 556; ICD10:K50, K51] Phase 1 [548169]
Company
Athpharma Ltd
Canonical SMILES
c1(c(cc(cc1)N)O)C(=O)[O-].[Na+]
Target and Pathway
Target(s) Cyclooxygenase Target Info Modulator [531873]
References
Ref 548169Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022712)
Ref 5318735-aminosalicylic acid mediates expression of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase to suppress colorectal tumorigenesis. Anticancer Res. 2012 Apr;32(4):1193-202.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.